Vertebral Compression Fractures… What should we be doing? (or not doing ….) Debra L. Bynum, MD Division of Geriatric Medicine University of North Carolina.

Download Report

Transcript Vertebral Compression Fractures… What should we be doing? (or not doing ….) Debra L. Bynum, MD Division of Geriatric Medicine University of North Carolina.

Vertebral
Compression
Fractures…
What should we be doing?
(or not doing ….)
Debra L. Bynum, MD
Division of Geriatric Medicine
University of North Carolina

“… I firmly believe that if the whole
materia medica as now used, could be
sunk to the bottom of the sea, it would
be all the better for mankind, -- and all
the worse for the fishes”

Oliver Wendell Holmes, address to the Massachusetts Medical
Society, 1860
Objectives

Understand the theory and basic
procedure involved in kyphoplasty and
vertebroplasty

Be able to weigh the risks and benefits
associated with these procedures

Identify key management strategies in
patients with compression fractures
Case

An 89 year old woman with HTN, mild
cognitive impairment, and osteoporosis
is admitted with 2 weeks of back pain
and is found to have a new thoracic
compression fracture.

Her daughter is a cardiologist at Duke
and is interested in pursuing possible
vertebroplasty….
From one website…

“A new therapy, Percutaneous
Vertebroplasty, is very effective in the
management of pain caused by
vertebral compression fractures. …
Percutaneous vertebroplasty can result
in relief of pain in 80-90% of patients.
The relief is usually achieved within 3
days of the procedure. For more
information about this advanced
procedure, speak to your pain
management physician…”
The case…

You ask a colleague about vertebroplasty,
and you are told
A
nonblind but randomized study in March
showed benefit, but two recent blinded,
randomized controlled studies showed no
benefit
 He
recommends “shared decision making”
– talk to the daughter and let her decide…
Background: Vertebral
Compression Fractures



Over 700,000 /year in U.S.
80% prevalence in women over age 80
Complications:
 Acute
pain and chronic pain
 Pulmonary dysfunction
 Loss of mobility
 Chronic spinal deformity
 Depression
 ?increased mortality (marker of frailty)
 Costly: $ 14 billion/year
Background:Vertebroplasty

Vertebroplasty (VP) introduced in France in
1984 by interventional neuroradiologist

VP used in US in 1993

1997: First case series of VP in U.S.
Kyphoplasty

Attempt to restore vertebral body height and reduce
kyphosis by using inflatable balloon tamp

Orthopedic surgery 1998

Height restoration (may be only 3-4 mm)

More expensive, often with general anesthesia

Less risk of cement leak
Background Data (prior to recent
studies of controversy…)

Multiple small studies of VP
demonstrating greater pain reduction,
less analgesic use, and greater mobility
compared to medical management
(initially and at few months)

3 meta-analyses show reduction in pain

Minimal complications
Background (cont)

KP with similar history: multiple small studies
demonstrating benefit with quicker reduction in pain
and mobilization compared to medical treatment

KP and VP: no studies clearly demonstrated any
benefit 1-2 years later when compared to medical
treatment

Procedures have increased exponentially
 Cement material previously FDA approved
 No FDA oversight for new procedures…
KP vs VP: Which is better?

KP: goal to restore height/reduce kyphosis, but may
only increase by 2-4 mm (no sig difference with VP)

KP with less cement leak (< 1% vs 3 % or more with
VP), although most leaks not symptomatic

Pain and other outcomes similar

Most likely similar, although patients referred for KP
often have more severe fractures
Complications

Cement Leak

Cement Pulmonary embolism (?higher
than thought)

Cord compression

Hematoma, infection
Complications…

?adjacent vertebral fractures (probable)

Most studies show increased risk

Problem: patients with compression fractures have high
probability of future fractures (25%/year)

Confounding: Those with worse disease more likely to have
VP/KP and more likely to have future fractures
Background – Way Back…

Long history of brave exploration of new
procedures and surgeries…
 Trephination
 First
of the skull, 10,000 BC…
appendectomy, 1736
 Coronary
stenting, spinal fusion, and now
vertebroplasty…
Ratios of Medicare Vertebroplasty Rates to the U.S. Average, According to Hospital Referral
Region (2001-2006)
Weinstein J. N Engl J Med 2009;361:619-621
Fracture Reduction Evaluation
(FREE) trial

Efficacy and safety of balloon
kyphoplasty compared with nonsurgical care for vertebral compression
fracture: a randomised controlled trial

Lancet March 2009
FREE trial

Patients with 1-3 acute vertebral fractures

149 patients randomized to KP, 151 controls

Primary outcome: change from baseline to 1
month in SF-36 physical component score
(PCS)

Also measured: QOL, safety up to 12 months
FREE: results

Mean PCS score improved 7.2 points (0-100 scale) in
KP group and only 2 points in control group at 1
month

More patients in control group needed walking aids,
back braces, PT, analgesics

KP: greater improvement in QOL

KP : 2.9 less days of restricted activity at 1 mo

No significant differences at 12 months…
Results
base
Walking aid/brace
Bedrest (>1d/14d)
Combo analgesic
Opioid
71%
58%
58%
16%
KP
Control
1month 12month
base
1month 12mo
33%
23%
41%
5%
72%
64%
56%
12%
61%
42%
57%
8%
26%
4%
24%
4%
41%
8%
29%
5%
FREE: problems…

Excluded patients with dementia

Not blinded (patients and radiologists)

Funded by Medtronic Spine

12 months: 38 (33%) in KP group and 24
(25%) had new/worsening VCF (p=.22)
Take Home (at the time)

Despite the problems, a well designed trial

Although no significant difference at 12 months…

Reduction in short term bedrest and need for opioid
analgesics that may be significant in this population

Recommended as possible benefit to select
patients…
New information…

NEJM August, 2009
Randomized Trial of Vertebroplasty
for Osteoporotic Spinal Fractures

131 patients with 1-3 painful
osteoporotic vertebral compression
fractures

Vertebroplasty vs simulated procedure

Primary outcome: Disability
Questionnaire (higher score=greater
disability) and patient’s rating of pain
RCT…

1 month: no significant difference in
RDQ score or pain rating (trend toward
improved pain in 64 % VP group vs 48
% control, p =.06)

Both groups had immediate
improvement in disability and pain
scores
Randomized Trial of Vertebroplasty for
Painful Osteoporotic Vertebral
Fractures

Double blind, placebo controlled, RCT

Patients with 1-2 painful osteoporotic
vertebral fractures less than 12 months and
“unhealed” on MRI

Primary outcome: Pain at 3 months

78 patients, 71 completed 6 month follow up
Results…

No difference between groups

Both had significant reduction in pain at 1 week, 1
month, 3 months, and 6 months

3 months (2.6 points in VP group, 1.9 in control
group)

Similar improvements in both groups with physical
functioning, QOL, and perceived improvement
Why the difference?
The RCT as Gold Standard

1753: naval surgeon James Lind publishes
account of comparative treatment of 12
scurvy patients:
 “their
cases as similar as I could have
them… the most sudden and visible good
effects were perceived from the use of the
oranges and lemons”
The RCT…

1930: Sollman suggests approach to problem
of investigator bias: use of blinded observer
and a placebo control

1932-1937: Harry Gold at Cornell refines the
double blind method and use of placebo

1935: Ronald Fisher’s “The Design of
Experiments” argues for use of strictly
randomized allocation
The RCT

Randomization made test groups more
comparable and “ethical”

1947: limited supply of streptomycin for
British patients, Bradford Hill in the BMJ
pushed for studies with a randomized
design:
 “precluded
the biases introduced by our personal
idiosyncracies, consciously or unconsciusly
applied, or lack of judgment”
RCT…

1960s: increase value on statistical
evidence in interpreting evidence

1990s: Evidence Based Medicine…
Won’t get fooled again…




Hip protectors and decreased hip fractures…
Estrogen use in postmenopausal women
decreases the risk of CAD (women on
estrogens live 1.5 years longer than those
not…)
Early coronary intervention must be good for
patients with diabetes and evidence for
significant but asymptomatic coronary
disease on angiography
Maybe trephination….
Problems with prior studies
looking at VP and KP

Not blinded


Bias on part of investigators (evidence that it“works”)
Bias of participants (advertised “evidence” that this works)

Underestimated placebo effect

Emphasis on “bioplausibility” (like HRT studies)

Favorable natural history of this disease

Confounders that no math can control for (HERS
study)
Are the results really different?

Although not “significant”, some suggestion
that pain is decreased at 1 month (similar to
FREE study)
 Care
with “not significant” as studies may not
have the power to see a difference
 Although
 Are
effect likely to be small…
we assuming too much that KP and VP are
similar in effect?
Concerns about the Validity of most
recently reported studies…

Outpatients (inpatients may have more severe pain)

Patients received 4 weeks of medical treatment –
patients on average had 9-16 weeks of symptoms in
the 2 recent VP studies (compared to 6 weeks for the
Lancet KP study)

Counter: no difference in subgroup analysis between
patients with less than or more than 6 weeks of
symptoms
Take Home

VP likely not much better than conservative
treatment, pain control, PT

Time will heal

Unclear what to do with KP, although likely
similar

VP and KP not without risk
Other Treatments…
Calcitonin for pain: Fact or
Lore?

Systematic review, only 5 decent
randomized, controlled studies

Reduced pain, immobility, analgesic
use

May help, take with a grain of salt…
Calcium and Vitamin D

Evidence that Ca and Vitamin D reduce
fractures

1200 mg/day Calcium
Vitamin D

Mounting evidence that deficiency is pandemic

Risk factors: darker skin, obesity, older age,
institutionalization

Receptors in every organ

Relationship with sarcopenia and wasting

Relationship to falls
Vitamin D… refresher

D2
 Ergocalciferol
 Plants,

dietary
D3
 Cholecalciferol
 Sun
exposure (UVB) and animal (salmon, cod
liver)

Metabolized..
 25
(OH) D in liver
 1,25 (OH) D in kidneys
Vitamin D: deficiency
25 (OH) D levels
 < 20: deficient
 > 30: not deficient
 Many need supplementation

 Cannot
recommend increase sun exposure
 Difficult to get enough in diet
Vitamin D: replacement

400 IU with MVI

Daily recommendations for those at
risk: 800- 1000 IU

Replacement:
 50,000
IU /week for 4-6 weeks, recheck
 Many will need to continue 50,000 /month
Other Treatment options…

Braces
 Poor
adherence
 If cord compromise/retropulsion, may
need shell
 Less restrictive: Jewitt
 May reduce pain by decreasing postural
flexion
Jewitt Brace
Treating Osteoporosis

Antiresorptive agents
 Block
osteoclastic activity
 Bisphosphonates
 Estrogen/hormone therapy
 Raloxifene
 Calcitonin

Anabolic agents
 Stimulation
of osteoblastic activity
 Teriparatide (recombinant PTH)
Treating Osteoporosis

Despite evidence that multiple agents
decrease future vertebral fractures, few
patients evaluated or treated after first
fragility fracture….
What Next?

How do we truly evaluate the efficacy of
procedures?
Health Technology Assessment
(HTA) program

Washington state legislature 2006

Government sponsored program using
formal methods to conduct critical appraisals
of surgical devices and procedures, medical
equipment, and diagnostic tests

FDA: low standards for devices, and surgical
procedures not regulated
HTA…
Pediatric bariatric surgery
 Lumbar fusion
 CT colonography
 Arthroscopy for OA of knee
 Coronary CT angiography

Obstacles…

Industry pressure (pressure put on Medicare
to cover )

Difficult to translate analysis of evidence
(effectiveness, safety, cost-effectiveness)
into coverage decision

?buy in from patients and providers?

Gary Franklin and Brain Budenholzer, NEJM Oct 2009
Summary Points: Vertebral
Compression Fractures

Most will heal with time

No clear evidence that VP or KP are better than
placebo over time

KP does not improve kyphosis, but may have less
risk of cement leak

Patients with vertebral compression fractures have
high risk of future fractures; There likely is a real
increase with VP or KP
Summary Points

Even in the most recent articles, there
may be a tendency toward decreased
pain initially after VP

There may be a role for patients who
are hospitalized with severe pain
requiring narcotics (small benefit in
this group may be worth the risk…)
Summary Points…

Consider Jewitt brace for comfort

Calcitonin may help for pain

Check for and treat vitamin D
deficiency

Treat the osteoporosis
Summary …. Final Points

No procedure is without risk

No statistical analysis is without risk

Treat the Osteoporosis